8-144882348-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001109689.4(ZNF250):c.835G>A(p.Glu279Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000657 in 1,613,838 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001109689.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF250 | NM_001109689.4 | c.835G>A | p.Glu279Lys | missense_variant | 6/6 | ENST00000417550.7 | NP_001103159.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF250 | ENST00000417550.7 | c.835G>A | p.Glu279Lys | missense_variant | 6/6 | 1 | NM_001109689.4 | ENSP00000393442 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152168Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000439 AC: 11AN: 250528Hom.: 0 AF XY: 0.0000517 AC XY: 7AN XY: 135432
GnomAD4 exome AF: 0.0000541 AC: 79AN: 1461552Hom.: 0 Cov.: 31 AF XY: 0.0000440 AC XY: 32AN XY: 727060
GnomAD4 genome AF: 0.000177 AC: 27AN: 152286Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74458
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2021 | The c.850G>A (p.E284K) alteration is located in exon 6 (coding exon 5) of the ZNF250 gene. This alteration results from a G to A substitution at nucleotide position 850, causing the glutamic acid (E) at amino acid position 284 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at